BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11039508)

  • 21. Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.
    Goedhals L; Falkson G; Smith BL; Falkson CI; Gasmi J; Lategan A; Burillon JP; His P
    Anticancer Res; 2005; 25(3c):2489-92. PubMed ID: 16080481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
    Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: a phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Ann Oncol; 1998 May; 9(5):565-7. PubMed ID: 9653499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
    Gebbia V; Mantovani G; Farris A; Agostara B; Desogus A; Curreli L; Moschella F; Di Gregorio C; Bajetta E; Gebbia N
    Cancer; 1997 Apr; 79(7):1394-400. PubMed ID: 9083162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study.
    Di Vagno G; Cormio G; Pignata S; Scambia G; Di Stefano MG; Tambaro R; Trerotoli P; Serio G; Garganese G; Selvaggi L
    Int J Gynecol Cancer; 2003; 13(3):308-12. PubMed ID: 12801261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.
    Papadimitriou CA; Kouroussis C; Moulopoulos LA; Vlahos G; Rodolakis A; Kiamouris C; Diakomanolis E; Gika D; Michalas S; Dimopoulos MA
    Cancer; 2001 Oct; 92(7):1856-63. PubMed ID: 11745258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
    Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
    Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
    Tabata T; Nishiura K; Yanoh K; Okugawa T; Obata H; Tanaka K; Toyoda N
    Int J Clin Oncol; 2004 Feb; 9(1):59-63. PubMed ID: 15162828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
    Rey F; Astoul P; Marqueste L; Petite JM; Boutin C; Viallat JR
    Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
    Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of ifosfamide in cervical cancer.
    Meanwell CA; Mould JJ; Blackledge G; Lawton FG; Stuart NS; Kavanagh J; Latief TN; Spooner D; Chetiyawardana AD
    Cancer Treat Rep; 1986 Jun; 70(6):727-30. PubMed ID: 3089596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.
    Perez JE; Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Lacava JA; Rodriguez R; Cuevas MA
    J Clin Oncol; 1993 Mar; 11(3):461-6. PubMed ID: 8445421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Koensgen D; Sehouli J; Belau A; Weiss M; Stope MB; Grokopf V; Eichbaum M; Ledwon P; Lichtenegger W; Zygmunt M; Köhler G; Mustea A
    Int J Gynecol Cancer; 2017 Mar; 27(3):500-506. PubMed ID: 28187089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.
    Kodama J; Takemoto M; Seki N; Nakamura K; Hongo A; Moriya S; Kanazawa S; Hiramatsu Y
    Int J Gynecol Cancer; 2008; 18(6):1300-4. PubMed ID: 18284451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.